Corporate information
Registration country
Company type
Web platform to accelerate science.Overview
Science has far-reaching implications for society, which is why the quality control process, known as ‘peer review’, is of high importance. However, the scientific validation process is ineffective, slow and centralized, and there are no incentives for academics and researchers to evaluate their quality of work. Orvium aims to improve the scientific validation process and reduce publication time. Scientists are connected through a web platform and can work together to streamline the process of scientific publishing. The platform offers decentralized peer reviews, which effectively reduces publication time, and all activity is stored on the blockchain for full traceability.
Funding rounds
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
CV VC AG | Private company based in Zug which invests in all stages of the crypto and blockchain growth cycle. | Initial investment. |
Investment activity status
Active investor
Team
| Employee | Position | ||
|---|---|---|---|
| Manuel Martin (founder) | |||
| Roberto Rabasco (founder) | |||
| Antonio Romero (founder) |